

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 7.19913294 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 7.19913294 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 7.19913294 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 7.19913294 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 7.19913294 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 7.19913294 |
| 7 | response to peptidoglycan (GO:0032494) | 6.01258511 |
| 8 | * regulation of vitamin D biosynthetic process (GO:0060556) | 5.94762996 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.12809787 |
| 10 | macrophage activation involved in immune response (GO:0002281) | 4.89806839 |
| 11 | * lipopolysaccharide-mediated signaling pathway (GO:0031663) | 4.74950340 |
| 12 | response to host immune response (GO:0052572) | 4.74103051 |
| 13 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.74103051 |
| 14 | * positive regulation of chemokine biosynthetic process (GO:0045080) | 4.66486522 |
| 15 | * regulation of vitamin metabolic process (GO:0030656) | 4.54862622 |
| 16 | * regulation of chronic inflammatory response (GO:0002676) | 4.50082832 |
| 17 | response to muramyl dipeptide (GO:0032495) | 4.47576525 |
| 18 | response to host (GO:0075136) | 4.29262038 |
| 19 | response to host defenses (GO:0052200) | 4.29262038 |
| 20 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 4.29262038 |
| 21 | regulation of interferon-alpha production (GO:0032647) | 4.23562067 |
| 22 | positive regulation of interferon-alpha production (GO:0032727) | 4.22274006 |
| 23 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.14713328 |
| 24 | respiratory burst (GO:0045730) | 4.12501970 |
| 25 | granulocyte activation (GO:0036230) | 4.07619712 |
| 26 | regulation of T-helper 1 cell differentiation (GO:0045625) | 4.06763607 |
| 27 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 4.05096490 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 4.04465125 |
| 29 | branching involved in labyrinthine layer morphogenesis (GO:0060670) | 4.02931119 |
| 30 | immunoglobulin mediated immune response (GO:0016064) | 3.99262705 |
| 31 | leukocyte aggregation (GO:0070486) | 3.92941458 |
| 32 | microglial cell activation (GO:0001774) | 3.91753248 |
| 33 | regulation of interferon-beta biosynthetic process (GO:0045357) | 3.84950301 |
| 34 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.84128150 |
| 35 | myeloid cell activation involved in immune response (GO:0002275) | 3.81815635 |
| 36 | superoxide anion generation (GO:0042554) | 3.80884876 |
| 37 | * regulation of chemokine biosynthetic process (GO:0045073) | 3.75714229 |
| 38 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 3.73179385 |
| 39 | regulation of interleukin-17 production (GO:0032660) | 3.72804773 |
| 40 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.72449963 |
| 41 | eosinophil chemotaxis (GO:0048245) | 3.72320590 |
| 42 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.70221295 |
| 43 | lymphocyte chemotaxis (GO:0048247) | 3.66492905 |
| 44 | reactive oxygen species biosynthetic process (GO:1903409) | 3.65721018 |
| 45 | T cell migration (GO:0072678) | 3.65183811 |
| 46 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.63159436 |
| 47 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.62872573 |
| 48 | macrophage activation (GO:0042116) | 3.62867741 |
| 49 | detection of molecule of bacterial origin (GO:0032490) | 3.59439547 |
| 50 | negative regulation of interleukin-17 production (GO:0032700) | 3.59166106 |
| 51 | positive regulation of interleukin-17 production (GO:0032740) | 3.58324307 |
| 52 | myeloid dendritic cell differentiation (GO:0043011) | 3.58310322 |
| 53 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.55682287 |
| 54 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 3.55630872 |
| 55 | * positive regulation of heat generation (GO:0031652) | 3.55132814 |
| 56 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.50915409 |
| 57 | CD4-positive or CD8-positive, alpha-beta T cell lineage commitment (GO:0043369) | 3.50739945 |
| 58 | monocyte chemotaxis (GO:0002548) | 3.47352126 |
| 59 | regulation of T-helper cell differentiation (GO:0045622) | 3.47337631 |
| 60 | defense response to protozoan (GO:0042832) | 3.45072110 |
| 61 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.43139617 |
| 62 | positive regulation of lymphocyte migration (GO:2000403) | 3.41941369 |
| 63 | positive regulation of interferon-beta production (GO:0032728) | 3.39984730 |
| 64 | eosinophil migration (GO:0072677) | 3.39321334 |
| 65 | positive regulation of interleukin-12 production (GO:0032735) | 3.38046076 |
| 66 | * regulation of cytokine secretion involved in immune response (GO:0002739) | 3.37749757 |
| 67 | * positive regulation of NF-kappaB import into nucleus (GO:0042346) | 3.34508242 |
| 68 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.34251343 |
| 69 | positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725) | 3.34011185 |
| 70 | * regulation of nitric oxide biosynthetic process (GO:0045428) | 3.33632460 |
| 71 | modulation by symbiont of host cellular process (GO:0044068) | 3.32127267 |
| 72 | I-kappaB phosphorylation (GO:0007252) | 3.31615721 |
| 73 | regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370) | 3.29066080 |
| 74 | positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372) | 3.27815832 |
| 75 | positive regulation of mast cell degranulation (GO:0043306) | 3.27488875 |
| 76 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 3.27488875 |
| 77 | * positive regulation of nitric oxide biosynthetic process (GO:0045429) | 3.27234587 |
| 78 | positive regulation of T-helper cell differentiation (GO:0045624) | 3.26756226 |
| 79 | neutrophil activation (GO:0042119) | 3.25823552 |
| 80 | * regulation of fever generation (GO:0031620) | 3.24970805 |
| 81 | NIK/NF-kappaB signaling (GO:0038061) | 3.24752494 |
| 82 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.24711015 |
| 83 | T-helper 1 type immune response (GO:0042088) | 3.23047375 |
| 84 | myeloid dendritic cell activation (GO:0001773) | 3.22705706 |
| 85 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.22647662 |
| 86 | regulation of mast cell degranulation (GO:0043304) | 3.20954520 |
| 87 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 3.20141845 |
| 88 | cellular response to type I interferon (GO:0071357) | 3.19836867 |
| 89 | type I interferon signaling pathway (GO:0060337) | 3.19836867 |
| 90 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.17985706 |
| 91 | response to type I interferon (GO:0034340) | 3.17781931 |
| 92 | cellular response to interferon-beta (GO:0035458) | 3.14892928 |
| 93 | low-density lipoprotein particle clearance (GO:0034383) | 3.14470545 |
| 94 | * regulation of heat generation (GO:0031650) | 3.13054492 |
| 95 | regulation of interleukin-12 production (GO:0032655) | 3.12831122 |
| 96 | positive regulation of interleukin-2 production (GO:0032743) | 3.12634729 |
| 97 | positive regulation of interleukin-10 production (GO:0032733) | 3.11400432 |
| 98 | * negative regulation of cytokine production involved in immune response (GO:0002719) | 3.10590364 |
| 99 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 3.10014941 |
| 100 | neutrophil chemotaxis (GO:0030593) | 3.09869524 |
| 101 | * regulation of NF-kappaB import into nucleus (GO:0042345) | 3.09682428 |
| 102 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.09386186 |
| 103 | positive regulation of T cell cytokine production (GO:0002726) | 3.09161312 |
| 104 | response to protozoan (GO:0001562) | 3.08292611 |
| 105 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 3.07100263 |
| 106 | regulation of type 2 immune response (GO:0002828) | 3.06695242 |
| 107 | cellular response to interferon-gamma (GO:0071346) | 3.05637287 |
| 108 | * regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.05126829 |
| 109 | positive regulation of interleukin-1 beta production (GO:0032731) | 3.03637704 |
| 110 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 3.02707828 |
| 111 | positive regulation of type 2 immune response (GO:0002830) | 3.01607005 |
| 112 | dendritic cell differentiation (GO:0097028) | 3.01234027 |
| 113 | neutrophil migration (GO:1990266) | 3.01146683 |
| 114 | * cellular response to lipopolysaccharide (GO:0071222) | 3.00703042 |
| 115 | * cellular response to molecule of bacterial origin (GO:0071219) | 3.00144788 |
| 116 | * positive regulation of acute inflammatory response (GO:0002675) | 2.99865663 |
| 117 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.99425637 |
| 118 | * positive regulation of interleukin-6 production (GO:0032755) | 2.98778727 |
| 119 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.97639255 |
| 120 | cytokine secretion (GO:0050663) | 2.96881502 |
| 121 | positive regulation of tumor necrosis factor production (GO:0032760) | 2.96210049 |
| 122 | detection of biotic stimulus (GO:0009595) | 2.96170293 |
| 123 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.95331213 |
| 124 | natural killer cell mediated immunity (GO:0002228) | 2.95331213 |
| 125 | germinal center formation (GO:0002467) | 2.95277163 |
| 126 | regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645) | 2.95092030 |
| 127 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.95014185 |
| 128 | myeloid leukocyte activation (GO:0002274) | 2.94316526 |
| 129 | positive regulation of antigen processing and presentation (GO:0002579) | 2.94227834 |
| 130 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.92448121 |
| 131 | * regulation of immunoglobulin secretion (GO:0051023) | 2.91970227 |
| 132 | * positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.90453794 |
| 133 | * negative regulation of viral genome replication (GO:0045071) | 2.90088712 |
| 134 | positive regulation of defense response to virus by host (GO:0002230) | 2.87508062 |
| 135 | regulation of CD4-positive, alpha-beta T cell activation (GO:2000514) | 2.87120008 |
| 136 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.86889410 |
| 137 | * cellular response to biotic stimulus (GO:0071216) | 2.86522451 |
| 138 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.85828310 |
| 139 | positive regulation of natural killer cell differentiation (GO:0032825) | 2.85782886 |
| 140 | * regulation of podosome assembly (GO:0071801) | 2.84943625 |
| 141 | positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516) | 2.84713867 |
| 142 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 2.82305622 |
| 143 | response to interferon-gamma (GO:0034341) | 2.82153968 |
| 144 | * positive regulation of cytokine biosynthetic process (GO:0042108) | 2.77442444 |
| 145 | regulation of toll-like receptor 4 signaling pathway (GO:0034143) | 2.76854636 |
| 146 | B cell mediated immunity (GO:0019724) | 2.76809890 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.88384920 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.87653827 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 6.42350162 |
| 4 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.32896608 |
| 5 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 4.30919865 |
| 6 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.91735393 |
| 7 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.90579437 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.87793509 |
| 9 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.81878584 |
| 10 | * RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.81785035 |
| 11 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.37903233 |
| 12 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.32014216 |
| 13 | * MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.18734701 |
| 14 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.04693014 |
| 15 | * EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.93168913 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.90214006 |
| 17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.75698651 |
| 18 | * STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.70623505 |
| 19 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.45796911 |
| 20 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.21196420 |
| 21 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.15446582 |
| 22 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 2.08651408 |
| 23 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.07335442 |
| 24 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.92513973 |
| 25 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.91854290 |
| 26 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.88764802 |
| 27 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.76496425 |
| 28 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.69932183 |
| 29 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.68103798 |
| 30 | SPI1_23127762_ChIP-Seq_K562_Human | 1.66568235 |
| 31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.65505191 |
| 32 | MYB_26560356_Chip-Seq_TH2_Human | 1.65166413 |
| 33 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.64484911 |
| 34 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.63931083 |
| 35 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.56342229 |
| 36 | * RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.56123129 |
| 37 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.51866307 |
| 38 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.50852370 |
| 39 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.50823352 |
| 40 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.46921472 |
| 41 | MYC_22102868_ChIP-Seq_BL_Human | 1.46192528 |
| 42 | MAF_26560356_Chip-Seq_TH1_Human | 1.44582650 |
| 43 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.42362785 |
| 44 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.40429237 |
| 45 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.35323198 |
| 46 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.31518875 |
| 47 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.29815754 |
| 48 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.28643898 |
| 49 | * MYB_26560356_Chip-Seq_TH1_Human | 1.26786146 |
| 50 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.24526995 |
| 51 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.22504499 |
| 52 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.21140320 |
| 53 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.20170209 |
| 54 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.18592176 |
| 55 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.18209977 |
| 56 | * MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16199984 |
| 57 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.16196414 |
| 58 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.13828883 |
| 59 | UTX_26944678_Chip-Seq_JUKART_Human | 1.12864896 |
| 60 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.12532523 |
| 61 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.12103416 |
| 62 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.12103416 |
| 63 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.12103416 |
| 64 | * NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.11642739 |
| 65 | * GATA3_26560356_Chip-Seq_TH2_Human | 1.11382385 |
| 66 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.10952082 |
| 67 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09713121 |
| 68 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.08838399 |
| 69 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.08291225 |
| 70 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.02185862 |
| 71 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01804347 |
| 72 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.00857638 |
| 73 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.98899464 |
| 74 | GATA1_22025678_ChIP-Seq_K562_Human | 0.98334656 |
| 75 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.97735132 |
| 76 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.96160533 |
| 77 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.95811550 |
| 78 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.94363477 |
| 79 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94128755 |
| 80 | * FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.90498039 |
| 81 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.89868335 |
| 82 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89321227 |
| 83 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.88298318 |
| 84 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.87385609 |
| 85 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.85723261 |
| 86 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.84312778 |
| 87 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.83750118 |
| 88 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.82680205 |
| 89 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.80235733 |
| 90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.80235733 |
| 91 | MAF_26560356_Chip-Seq_TH2_Human | 0.79860653 |
| 92 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.79799336 |
| 93 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.79623426 |
| 94 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.79323357 |
| 95 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.78917356 |
| 96 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.78799860 |
| 97 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.78073811 |
| 98 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.75825883 |
| 99 | GATA2_19941826_ChIP-Seq_K562_Human | 0.75319154 |
| 100 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.74277743 |
| 101 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.73841324 |
| 102 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.73742905 |
| 103 | GATA1_19941826_ChIP-Seq_K562_Human | 0.73456596 |
| 104 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.72881825 |
| 105 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.72881825 |
| 106 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.72316613 |
| 107 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.71785194 |
| 108 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.71768972 |
| 109 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69851324 |
| 110 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.69325787 |
| 111 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.68726072 |
| 112 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.68693725 |
| 113 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.68352852 |
| 114 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.68329279 |
| 115 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 0.67351622 |
| 116 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.65291323 |
| 117 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.64755452 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0006082_CNS_inflammation | 4.35936437 |
| 2 | MP0003303_peritoneal_inflammation | 4.30205577 |
| 3 | * MP0009785_altered_susceptibility_to | 4.05546212 |
| 4 | MP0001835_abnormal_antigen_presentation | 4.02210632 |
| 5 | * MP0003436_decreased_susceptibility_to | 3.70240001 |
| 6 | MP0002148_abnormal_hypersensitivity_rea | 3.58625686 |
| 7 | * MP0005000_abnormal_immune_tolerance | 3.34191496 |
| 8 | * MP0002419_abnormal_innate_immunity | 3.25689863 |
| 9 | MP0003724_increased_susceptibility_to | 3.22616895 |
| 10 | * MP0005025_abnormal_response_to | 3.02314990 |
| 11 | MP0004510_myositis | 2.84803168 |
| 12 | MP0001790_abnormal_immune_system | 2.67006734 |
| 13 | MP0005387_immune_system_phenotype | 2.67006734 |
| 14 | * MP0002452_abnormal_antigen_presenting | 2.57824818 |
| 15 | * MP0002723_abnormal_immune_serum | 2.53767926 |
| 16 | MP0000685_abnormal_immune_system | 2.52836364 |
| 17 | MP0005058_abnormal_lysosome_morphology | 2.48752544 |
| 18 | * MP0001800_abnormal_humoral_immune | 2.45700793 |
| 19 | MP0009278_abnormal_bone_marrow | 2.35697309 |
| 20 | * MP0004947_skin_inflammation | 2.20140635 |
| 21 | MP0001853_heart_inflammation | 2.19559245 |
| 22 | MP0002139_abnormal_hepatobiliary_system | 2.19529021 |
| 23 | * MP0001819_abnormal_immune_cell | 2.13299567 |
| 24 | MP0005464_abnormal_platelet_physiology | 2.12580294 |
| 25 | MP0003172_abnormal_lysosome_physiology | 2.11835798 |
| 26 | * MP0002420_abnormal_adaptive_immunity | 2.11081832 |
| 27 | MP0003300_gastrointestinal_ulcer | 2.10115653 |
| 28 | * MP0001533_abnormal_skeleton_physiology | 2.07516387 |
| 29 | MP0002405_respiratory_system_inflammati | 2.06770113 |
| 30 | * MP0005671_abnormal_response_to | 1.99037329 |
| 31 | * MP0001845_abnormal_inflammatory_respons | 1.90438607 |
| 32 | * MP0009764_decreased_sensitivity_to | 1.85817959 |
| 33 | MP0009333_abnormal_splenocyte_physiolog | 1.85312937 |
| 34 | MP0003448_altered_tumor_morphology | 1.83148027 |
| 35 | MP0009840_abnormal_foam_cell | 1.81038475 |
| 36 | MP0003075_altered_response_to | 1.80103870 |
| 37 | MP0000604_amyloidosis | 1.78571968 |
| 38 | MP0002006_tumorigenesis | 1.75569482 |
| 39 | MP0010155_abnormal_intestine_physiology | 1.73886960 |
| 40 | * MP0008469_abnormal_protein_level | 1.73322818 |
| 41 | MP0000343_altered_response_to | 1.71841612 |
| 42 | MP0000569_abnormal_digit_pigmentation | 1.55043083 |
| 43 | MP0002998_abnormal_bone_remodeling | 1.51784020 |
| 44 | * MP0000716_abnormal_immune_system | 1.45268097 |
| 45 | MP0005167_abnormal_blood-brain_barrier | 1.41485672 |
| 46 | MP0000858_altered_metastatic_potential | 1.39105712 |
| 47 | * MP0002398_abnormal_bone_marrow | 1.37636079 |
| 48 | MP0001545_abnormal_hematopoietic_system | 1.36026744 |
| 49 | MP0005397_hematopoietic_system_phenotyp | 1.36026744 |
| 50 | MP0005166_decreased_susceptibility_to | 1.33206041 |
| 51 | MP0006054_spinal_hemorrhage | 1.32806244 |
| 52 | MP0005310_abnormal_salivary_gland | 1.29086400 |
| 53 | MP0005164_abnormal_response_to | 1.23382241 |
| 54 | MP0003690_abnormal_glial_cell | 1.22514078 |
| 55 | MP0003195_calcinosis | 1.21304651 |
| 56 | MP0001851_eye_inflammation | 1.18348620 |
| 57 | * MP0000689_abnormal_spleen_morphology | 1.18081222 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.15821924 |
| 59 | MP0002138_abnormal_hepatobiliary_system | 1.15489475 |
| 60 | * MP0002429_abnormal_blood_cell | 1.14216623 |
| 61 | MP0003183_abnormal_peptide_metabolism | 1.14202947 |
| 62 | MP0004858_abnormal_nervous_system | 1.13268004 |
| 63 | MP0002332_abnormal_exercise_endurance | 1.10514798 |
| 64 | MP0003806_abnormal_nucleotide_metabolis | 1.07859154 |
| 65 | MP0003828_pulmonary_edema | 1.05810973 |
| 66 | MP0002254_reproductive_system_inflammat | 1.04740153 |
| 67 | * MP0002722_abnormal_immune_system | 1.04373153 |
| 68 | MP0002933_joint_inflammation | 1.03860838 |
| 69 | MP0008260_abnormal_autophagy | 1.01284007 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 0.99180119 |
| 71 | MP0010307_abnormal_tumor_latency | 0.98020864 |
| 72 | * MP0005390_skeleton_phenotype | 0.96572466 |
| 73 | MP0004782_abnormal_surfactant_physiolog | 0.95205919 |
| 74 | MP0003186_abnormal_redox_activity | 0.95126859 |
| 75 | * MP0009763_increased_sensitivity_to | 0.94232904 |
| 76 | MP0010352_gastrointestinal_tract_polyps | 0.89910766 |
| 77 | MP0002277_abnormal_respiratory_mucosa | 0.85498161 |
| 78 | MP0001958_emphysema | 0.84907955 |
| 79 | MP0001542_abnormal_bone_strength | 0.84806909 |
| 80 | MP0002166_altered_tumor_susceptibility | 0.82348427 |
| 81 | MP0003646_muscle_fatigue | 0.81269516 |
| 82 | MP0003656_abnormal_erythrocyte_physiolo | 0.81098673 |
| 83 | MP0005535_abnormal_body_temperature | 0.81037803 |
| 84 | MP0003763_abnormal_thymus_physiology | 0.80854606 |
| 85 | MP0000249_abnormal_blood_vessel | 0.80802769 |
| 86 | MP0005257_abnormal_intraocular_pressure | 0.76423994 |
| 87 | MP0005174_abnormal_tail_pigmentation | 0.75392928 |
| 88 | MP0000371_diluted_coat_color | 0.73521215 |
| 89 | MP0003091_abnormal_cell_migration | 0.71805932 |
| 90 | MP0008874_decreased_physiological_sensi | 0.70895715 |
| 91 | MP0005266_abnormal_metabolism | 0.70668467 |
| 92 | MP0003795_abnormal_bone_structure | 0.67564540 |
| 93 | MP0000465_gastrointestinal_hemorrhage | 0.66586929 |
| 94 | * MP0003453_abnormal_keratinocyte_physiol | 0.66412913 |
| 95 | MP0005083_abnormal_biliary_tract | 0.66123265 |
| 96 | MP0003045_fibrosis | 0.65255175 |
| 97 | MP0005023_abnormal_wound_healing | 0.63270461 |
| 98 | MP0003566_abnormal_cell_adhesion | 0.62579693 |
| 99 | MP0001727_abnormal_embryo_implantation | 0.60175389 |
| 100 | MP0001873_stomach_inflammation | 0.60005636 |
| 101 | MP0008004_abnormal_stomach_pH | 0.59748242 |
| 102 | MP0004808_abnormal_hematopoietic_stem | 0.59203900 |
| 103 | MP0005451_abnormal_body_composition | 0.58701254 |
| 104 | MP0009765_abnormal_xenobiotic_induced | 0.57922089 |
| 105 | MP0005666_abnormal_adipose_tissue | 0.57425994 |
| 106 | MP0000920_abnormal_myelination | 0.56523238 |
| 107 | * MP0001501_abnormal_sleep_pattern | 0.56405204 |
| 108 | MP0004883_abnormal_blood_vessel | 0.56324153 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.55545266 |
| 110 | MP0001663_abnormal_digestive_system | 0.55464218 |
| 111 | * MP0005165_increased_susceptibility_to | 0.55157936 |
| 112 | MP0000490_abnormal_crypts_of | 0.54866755 |
| 113 | MP0002693_abnormal_pancreas_physiology | 0.53593079 |
| 114 | MP0003866_abnormal_defecation | 0.53356639 |
| 115 | MP0002877_abnormal_melanocyte_morpholog | 0.53244894 |
| 116 | MP0005381_digestive/alimentary_phenotyp | 0.53120811 |
| 117 | MP0001764_abnormal_homeostasis | 0.49787003 |
| 118 | MP0000703_abnormal_thymus_morphology | 0.49594815 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 7.41660888 |
| 2 | Eczematoid dermatitis (HP:0000976) | 7.11589722 |
| 3 | Stomatitis (HP:0010280) | 6.93679613 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 6.83711184 |
| 5 | Elevated erythrocyte sedimentation rate (HP:0003565) | 6.56470005 |
| 6 | Recurrent gram-negative bacterial infections (HP:0005420) | 6.20413216 |
| 7 | Mediastinal lymphadenopathy (HP:0100721) | 5.76296743 |
| 8 | Abnormality of macrophages (HP:0004311) | 5.52172839 |
| 9 | Orchitis (HP:0100796) | 5.17853631 |
| 10 | Optic neuritis (HP:0100653) | 5.02498836 |
| 11 | Retrobulbar optic neuritis (HP:0100654) | 5.02498836 |
| 12 | Myositis (HP:0100614) | 4.78748605 |
| 13 | Autoimmune thrombocytopenia (HP:0001973) | 4.51999178 |
| 14 | Gingivitis (HP:0000230) | 4.33847113 |
| 15 | Increased cerebral lipofuscin (HP:0011813) | 4.24604204 |
| 16 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.10196813 |
| 17 | Recurrent skin infections (HP:0001581) | 3.97399495 |
| 18 | Vasculitis (HP:0002633) | 3.95102984 |
| 19 | Systemic lupus erythematosus (HP:0002725) | 3.88299444 |
| 20 | Obstructive lung disease (HP:0006536) | 3.77437059 |
| 21 | Chronic obstructive pulmonary disease (HP:0006510) | 3.77437059 |
| 22 | Recurrent fungal infections (HP:0002841) | 3.59648765 |
| 23 | Vacuolated lymphocytes (HP:0001922) | 3.56544326 |
| 24 | Axonal loss (HP:0003447) | 3.54560618 |
| 25 | Increased IgM level (HP:0003496) | 3.45073010 |
| 26 | Mutism (HP:0002300) | 3.36096181 |
| 27 | Pulmonary infiltrates (HP:0002113) | 3.33698492 |
| 28 | Interstitial pulmonary disease (HP:0006530) | 3.25429055 |
| 29 | Urticaria (HP:0001025) | 3.21532284 |
| 30 | Nuclear cataract (HP:0100018) | 3.20646089 |
| 31 | Autoimmune hemolytic anemia (HP:0001890) | 3.15694837 |
| 32 | Recurrent viral infections (HP:0004429) | 3.15029893 |
| 33 | Tetraparesis (HP:0002273) | 3.09733071 |
| 34 | Thick nail (HP:0001805) | 2.99321637 |
| 35 | Basal ganglia calcification (HP:0002135) | 2.99121205 |
| 36 | Prostate neoplasm (HP:0100787) | 2.89937928 |
| 37 | Periodontitis (HP:0000704) | 2.89921115 |
| 38 | Keratoconjunctivitis sicca (HP:0001097) | 2.86375829 |
| 39 | Amyloidosis (HP:0011034) | 2.82593625 |
| 40 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.82477018 |
| 41 | Neurofibrillary tangles (HP:0002185) | 2.82386728 |
| 42 | Cellulitis (HP:0100658) | 2.82356990 |
| 43 | Leukocytosis (HP:0001974) | 2.80956352 |
| 44 | Pustule (HP:0200039) | 2.80027952 |
| 45 | Disinhibition (HP:0000734) | 2.79299542 |
| 46 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.73254516 |
| 47 | Apathy (HP:0000741) | 2.72093240 |
| 48 | Arterial thrombosis (HP:0004420) | 2.70964651 |
| 49 | Encephalitis (HP:0002383) | 2.63306141 |
| 50 | Keratoconjunctivitis (HP:0001096) | 2.60627856 |
| 51 | Diminished motivation (HP:0000745) | 2.59900297 |
| 52 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.57736368 |
| 53 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.57736368 |
| 54 | Abnormality of glycolipid metabolism (HP:0010969) | 2.57736368 |
| 55 | IgA deficiency (HP:0002720) | 2.55018225 |
| 56 | Meningitis (HP:0001287) | 2.52972897 |
| 57 | Glomerulonephritis (HP:0000099) | 2.47834159 |
| 58 | Premature loss of primary teeth (HP:0006323) | 2.47505689 |
| 59 | Osteomyelitis (HP:0002754) | 2.46515250 |
| 60 | Dysostosis multiplex (HP:0000943) | 2.46303105 |
| 61 | Hematochezia (HP:0002573) | 2.42675221 |
| 62 | Hepatosplenomegaly (HP:0001433) | 2.41232403 |
| 63 | Myocardial infarction (HP:0001658) | 2.38668350 |
| 64 | Recurrent pneumonia (HP:0006532) | 2.36426304 |
| 65 | Abnormality of B cell number (HP:0010975) | 2.35318988 |
| 66 | Progressive neurologic deterioration (HP:0002344) | 2.34872839 |
| 67 | B lymphocytopenia (HP:0010976) | 2.34268162 |
| 68 | Gingival bleeding (HP:0000225) | 2.33143467 |
| 69 | Recurrent cutaneous fungal infections (HP:0011370) | 2.31574212 |
| 70 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.31574212 |
| 71 | Anorexia (HP:0002039) | 2.29404889 |
| 72 | Hemoptysis (HP:0002105) | 2.28394355 |
| 73 | Bone pain (HP:0002653) | 2.28298734 |
| 74 | Inappropriate behavior (HP:0000719) | 2.28040523 |
| 75 | Hypergammaglobulinemia (HP:0010702) | 2.27171190 |
| 76 | Abnormality of the pericardium (HP:0001697) | 2.23769285 |
| 77 | Vertigo (HP:0002321) | 2.22758889 |
| 78 | Abnormality of the pleura (HP:0002103) | 2.21592915 |
| 79 | Increased IgE level (HP:0003212) | 2.18867975 |
| 80 | Neuronal loss in central nervous system (HP:0002529) | 2.16531007 |
| 81 | Vertebral compression fractures (HP:0002953) | 2.16335467 |
| 82 | Abnormality of iron homeostasis (HP:0011031) | 2.13425179 |
| 83 | Petechiae (HP:0000967) | 2.12733718 |
| 84 | Joint swelling (HP:0001386) | 2.12172771 |
| 85 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.11730751 |
| 86 | Peritonitis (HP:0002586) | 2.11411297 |
| 87 | Keratitis (HP:0000491) | 2.11268746 |
| 88 | Memory impairment (HP:0002354) | 2.10745287 |
| 89 | Arthralgia (HP:0002829) | 2.08013347 |
| 90 | Metaphyseal irregularity (HP:0003025) | 2.07187009 |
| 91 | Pulmonary embolism (HP:0002204) | 2.06601305 |
| 92 | Mucopolysacchariduria (HP:0008155) | 2.05989298 |
| 93 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.05989298 |
| 94 | Combined immunodeficiency (HP:0005387) | 2.02831066 |
| 95 | Gastrointestinal infarctions (HP:0005244) | 2.02671817 |
| 96 | Glomerulopathy (HP:0100820) | 2.02453577 |
| 97 | Acne (HP:0001061) | 2.01390680 |
| 98 | Restrictive lung disease (HP:0002091) | 2.01223700 |
| 99 | Cerebral inclusion bodies (HP:0100314) | 2.00503386 |
| 100 | Nephritis (HP:0000123) | 1.99894587 |
| 101 | Recurrent lower respiratory tract infections (HP:0002783) | 1.99456684 |
| 102 | Agnosia (HP:0010524) | 1.99375898 |
| 103 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.99285491 |
| 104 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.99285491 |
| 105 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.99285491 |
| 106 | Poor head control (HP:0002421) | 1.99012734 |
| 107 | Lymphopenia (HP:0001888) | 1.98080071 |
| 108 | Chronic otitis media (HP:0000389) | 1.97785119 |
| 109 | Abnormality of the endocardium (HP:0004306) | 1.97706037 |
| 110 | Abnormality of T cell number (HP:0011839) | 1.97196083 |
| 111 | Episodic fever (HP:0001954) | 1.96219053 |
| 112 | Recurrent bronchitis (HP:0002837) | 1.96004278 |
| 113 | Porencephaly (HP:0002132) | 1.95878801 |
| 114 | Neoplasm of head and neck (HP:0012288) | 1.95586350 |
| 115 | Esophageal neoplasm (HP:0100751) | 1.95586350 |
| 116 | Parakeratosis (HP:0001036) | 1.94413575 |
| 117 | Pathologic fracture (HP:0002756) | 1.91567437 |
| 118 | Joint hemorrhage (HP:0005261) | 1.91527323 |
| 119 | Increased serum ferritin (HP:0003281) | 1.90500924 |
| 120 | Gastrointestinal stroma tumor (HP:0100723) | 1.89218543 |
| 121 | Purpura (HP:0000979) | 1.85577259 |
| 122 | Polyneuropathy (HP:0001271) | 1.82506590 |
| 123 | T lymphocytopenia (HP:0005403) | 1.78084329 |
| 124 | Peripheral demyelination (HP:0011096) | 1.77430002 |
| 125 | Loss of speech (HP:0002371) | 1.75933926 |
| 126 | Gangrene (HP:0100758) | 1.75391572 |
| 127 | Splenomegaly (HP:0001744) | 1.75364366 |
| 128 | Colitis (HP:0002583) | 1.75338036 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K14 | 5.17005392 |
| 2 | RIPK4 | 4.34652050 |
| 3 | TBK1 | 4.21184445 |
| 4 | IRAK3 | 3.79449022 |
| 5 | TXK | 3.62219819 |
| 6 | MAP4K1 | 3.17690668 |
| 7 | IKBKE | 3.16095774 |
| 8 | IRAK4 | 3.14287312 |
| 9 | BLK | 3.05812975 |
| 10 | ERN1 | 3.01109860 |
| 11 | DDR2 | 2.88433934 |
| 12 | TYK2 | 2.83450527 |
| 13 | IKBKB | 2.79092917 |
| 14 | PRPF4B | 2.38701146 |
| 15 | JAK3 | 2.25364688 |
| 16 | CHUK | 1.88639041 |
| 17 | PBK | 1.87350982 |
| 18 | KIT | 1.75593451 |
| 19 | ZAP70 | 1.74690149 |
| 20 | PIM2 | 1.73351655 |
| 21 | MAP3K13 | 1.73059153 |
| 22 | CSK | 1.70723268 |
| 23 | FGR | 1.66129994 |
| 24 | JAK1 | 1.65485993 |
| 25 | BMX | 1.49203532 |
| 26 | ADRBK2 | 1.37909353 |
| 27 | CDC42BPA | 1.36212491 |
| 28 | HCK | 1.35339427 |
| 29 | SYK | 1.28864139 |
| 30 | RPS6KA4 | 1.23601409 |
| 31 | TYRO3 | 1.22987568 |
| 32 | BMPR2 | 1.16233292 |
| 33 | LYN | 1.14643463 |
| 34 | LCK | 1.13322121 |
| 35 | MARK3 | 1.06789638 |
| 36 | ABL2 | 1.06777835 |
| 37 | EIF2AK2 | 1.04129807 |
| 38 | FES | 1.01743287 |
| 39 | PIM1 | 1.01288042 |
| 40 | JAK2 | 0.98971985 |
| 41 | MST1R | 0.98878624 |
| 42 | CSF1R | 0.97237846 |
| 43 | STK10 | 0.97086964 |
| 44 | MAP3K5 | 0.96389852 |
| 45 | EPHB1 | 0.92275354 |
| 46 | BTK | 0.91387205 |
| 47 | SIK2 | 0.90873258 |
| 48 | MAP3K10 | 0.88750065 |
| 49 | TAOK3 | 0.82938507 |
| 50 | MATK | 0.81290240 |
| 51 | TEC | 0.80273079 |
| 52 | ERBB4 | 0.80188455 |
| 53 | MAP3K11 | 0.79598169 |
| 54 | SIK3 | 0.79073780 |
| 55 | EGFR | 0.75118548 |
| 56 | ACVR1B | 0.73486941 |
| 57 | CDK12 | 0.72782918 |
| 58 | IRAK2 | 0.71253235 |
| 59 | RIPK1 | 0.68376702 |
| 60 | NME2 | 0.68167215 |
| 61 | ABL1 | 0.67610762 |
| 62 | PRKCD | 0.65047789 |
| 63 | TGFBR2 | 0.63129603 |
| 64 | ITK | 0.62970173 |
| 65 | LATS2 | 0.61096038 |
| 66 | PKN1 | 0.59920203 |
| 67 | TAOK2 | 0.58900350 |
| 68 | MST4 | 0.58532445 |
| 69 | MAP3K3 | 0.57770662 |
| 70 | MAP2K3 | 0.57624807 |
| 71 | HIPK2 | 0.55776292 |
| 72 | YES1 | 0.54793603 |
| 73 | TTN | 0.54028445 |
| 74 | IRAK1 | 0.53968631 |
| 75 | CLK1 | 0.52925890 |
| 76 | MAP2K6 | 0.49531759 |
| 77 | TAOK1 | 0.49045657 |
| 78 | KSR2 | 0.48893694 |
| 79 | PDGFRA | 0.48615233 |
| 80 | DYRK3 | 0.48495961 |
| 81 | EPHA3 | 0.48136688 |
| 82 | MAP3K1 | 0.47437210 |
| 83 | NEK9 | 0.44574439 |
| 84 | DAPK3 | 0.42367624 |
| 85 | FGFR3 | 0.42063147 |
| 86 | TESK2 | 0.40977820 |
| 87 | FYN | 0.39999059 |
| 88 | PTK6 | 0.39515435 |
| 89 | DAPK2 | 0.37738745 |
| 90 | GRK7 | 0.36774612 |
| 91 | LRRK2 | 0.36479073 |
| 92 | MAPK7 | 0.35391009 |
| 93 | PRKG2 | 0.35130395 |
| 94 | STK3 | 0.34505373 |
| 95 | FGFR4 | 0.32694730 |
| 96 | PRKCQ | 0.32167407 |
| 97 | INSR | 0.31359254 |
| 98 | PDGFRB | 0.30535743 |
| 99 | RPS6KA1 | 0.30220710 |
| 100 | CDK4 | 0.29871006 |
| 101 | PDK2 | 0.29277409 |
| 102 | STK4 | 0.28312757 |
| 103 | CAMK1D | 0.27733881 |
| 104 | CDK6 | 0.27504758 |
| 105 | MOS | 0.27347289 |
| 106 | MAPKAPK2 | 0.26889610 |
| 107 | GSK3A | 0.25933686 |
| 108 | SIK1 | 0.24187546 |
| 109 | ALK | 0.24137619 |
| 110 | STK24 | 0.23833018 |
| 111 | RPS6KA6 | 0.23600693 |
| 112 | MAPK4 | 0.23538961 |
| 113 | PDK1 | 0.23089547 |
| 114 | IGF1R | 0.21063934 |
| 115 | RPS6KL1 | 0.20506010 |
| 116 | RPS6KC1 | 0.20506010 |
| 117 | CAMKK2 | 0.20291846 |
| 118 | PDPK1 | 0.20273762 |
| 119 | MUSK | 0.19467949 |
| 120 | ARAF | 0.19455737 |
| 121 | SRC | 0.14829917 |
| 122 | ICK | 0.13320497 |
| 123 | MAP3K8 | 0.13129183 |
| 124 | MAPK3 | 0.10526378 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Leishmaniasis_Homo sapiens_hsa05140 | 3.56017573 |
| 2 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 3.48758079 |
| 3 | * NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.96727141 |
| 4 | * NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 2.96134357 |
| 5 | * Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.94380882 |
| 6 | * Legionellosis_Homo sapiens_hsa05134 | 2.86420235 |
| 7 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.86288297 |
| 8 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.74294858 |
| 9 | * Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.64409634 |
| 10 | * Malaria_Homo sapiens_hsa05144 | 2.52339032 |
| 11 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.44982798 |
| 12 | * TNF signaling pathway_Homo sapiens_hsa04668 | 2.44103096 |
| 13 | * Allograft rejection_Homo sapiens_hsa05330 | 2.39561429 |
| 14 | * Pertussis_Homo sapiens_hsa05133 | 2.30868142 |
| 15 | * Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.28550642 |
| 16 | * Tuberculosis_Homo sapiens_hsa05152 | 2.26816400 |
| 17 | * Type I diabetes mellitus_Homo sapiens_hsa04940 | 2.26575011 |
| 18 | Salmonella infection_Homo sapiens_hsa05132 | 2.22038771 |
| 19 | Measles_Homo sapiens_hsa05162 | 2.13150692 |
| 20 | * Asthma_Homo sapiens_hsa05310 | 2.13094655 |
| 21 | * RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.07907220 |
| 22 | * Influenza A_Homo sapiens_hsa05164 | 1.83656967 |
| 23 | * Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.77638569 |
| 24 | * African trypanosomiasis_Homo sapiens_hsa05143 | 1.76028380 |
| 25 | * Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.65278619 |
| 26 | * Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.61826213 |
| 27 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.61114007 |
| 28 | Phagosome_Homo sapiens_hsa04145 | 1.55931319 |
| 29 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.52642577 |
| 30 | Lysosome_Homo sapiens_hsa04142 | 1.49930937 |
| 31 | * Toxoplasmosis_Homo sapiens_hsa05145 | 1.42997620 |
| 32 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.42400600 |
| 33 | * Herpes simplex infection_Homo sapiens_hsa05168 | 1.40193014 |
| 34 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40034740 |
| 35 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.38977565 |
| 36 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.34267849 |
| 37 | Shigellosis_Homo sapiens_hsa05131 | 1.33119901 |
| 38 | * Apoptosis_Homo sapiens_hsa04210 | 1.18821388 |
| 39 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.15240524 |
| 40 | * T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.09494876 |
| 41 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.08147508 |
| 42 | * Amoebiasis_Homo sapiens_hsa05146 | 1.07755405 |
| 43 | * AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.02439026 |
| 44 | * Hepatitis B_Homo sapiens_hsa05161 | 1.01507367 |
| 45 | * Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.00412665 |
| 46 | * Hepatitis C_Homo sapiens_hsa05160 | 0.98294633 |
| 47 | Prion diseases_Homo sapiens_hsa05020 | 0.92809520 |
| 48 | Bladder cancer_Homo sapiens_hsa05219 | 0.92281527 |
| 49 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.90374694 |
| 50 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.87725429 |
| 51 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78531886 |
| 52 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.73954025 |
| 53 | Other glycan degradation_Homo sapiens_hsa00511 | 0.73515056 |
| 54 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.71795226 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.68888828 |
| 56 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.67255890 |
| 57 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.67035635 |
| 58 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.62656325 |
| 59 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 0.62401437 |
| 60 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.61362634 |
| 61 | * Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.60604828 |
| 62 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59425672 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.53322323 |
| 64 | Mineral absorption_Homo sapiens_hsa04978 | 0.52914805 |
| 65 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.52888970 |
| 66 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.48653807 |
| 67 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.47039227 |
| 68 | * Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.46202178 |
| 69 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.43381482 |
| 70 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.42706845 |
| 71 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.41429187 |
| 72 | Platelet activation_Homo sapiens_hsa04611 | 0.39969622 |
| 73 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.39069938 |
| 74 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.38430478 |
| 75 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38066020 |
| 76 | * Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.35450906 |
| 77 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.35368394 |
| 78 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.34820649 |
| 79 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.32339147 |
| 80 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.31843545 |
| 81 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.31190669 |
| 82 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.26140994 |
| 83 | * HTLV-I infection_Homo sapiens_hsa05166 | 0.25925343 |
| 84 | * Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.25575712 |
| 85 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.25557278 |
| 86 | * Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.25331253 |
| 87 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.23685318 |
| 88 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.23591752 |
| 89 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.23223264 |
| 90 | * Insulin resistance_Homo sapiens_hsa04931 | 0.22855385 |
| 91 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.22427977 |
| 92 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.19618068 |
| 93 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.19530557 |
| 94 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19194263 |
| 95 | * MAPK signaling pathway_Homo sapiens_hsa04010 | 0.16969583 |
| 96 | * Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.16347372 |
| 97 | Endocytosis_Homo sapiens_hsa04144 | 0.16262317 |
| 98 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.15510831 |
| 99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.14645554 |
| 100 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.13615841 |
| 101 | Galactose metabolism_Homo sapiens_hsa00052 | 0.13209746 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.12884532 |
| 103 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.12497943 |
| 104 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.11347343 |
| 105 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.10978447 |
| 106 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.09865320 |
| 107 | * Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.09018625 |
| 108 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.08489834 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.06123310 |
| 110 | Prostate cancer_Homo sapiens_hsa05215 | 0.06031394 |
| 111 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.05527095 |

